what is glp-1 drug made from Can one do it all? Reviewing the expanding clinical universe of agonists Compound versions of GLP-1 drugs
Description
Cardiovascular outcomes trials have demonstrated reduced rates of major adverse cardiovascular events in high-risk patients treated with liraglutide (LEADER trial) and semaglutide (SUSTAIN-6 trial)
Fatty Acid Modifications: Exploiting the interactions between fatty acids and albumin to achieve metabolic stability and circulation, while using the self-assembly and ionic properties of fatty acids to prolong the drugs half-life
In addition, the annual eGFR decline was lower for semaglutide by 1.16 mL/min/1.73 m 2 compared with placebo (15)
doi: 10.2337/db18-0729, 67 HristakevaS.LiaukonyteJ.FelerL
Create an account or log in to save stories
Both contain semaglutide, but they are different products
